Cardlytics
CDLX
153 hedge funds and large institutions have $1.83B invested in Cardlytics in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 31 closing their positions.
22% more funds holding in top 10
Funds holding in top 10: 9 → 11 (+2)
16% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 49
0.01% less ownership
Funds ownership: 9.88% → 9.87% (-0.01%)
6% less funds holding
Funds holding: 163 → 153 (-10)
16% less capital invested
Capital invested by funds: $2.17B → $1.83B (-$340M)
29% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 31
71% less call options, than puts
Call options by funds: $7.07M | Put options by funds: $24.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JCM
JS Capital Management
New York
|
+$23.4M |
| 2 |
CIP
CAS Investment Partners
Westport,
Connecticut
|
+$13.9M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$8.36M |
| 4 |
Goldman Sachs
New York
|
+$8.08M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$5.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.1M |
| 2 |
Morgan Stanley
New York
|
-$10.5M |
| 3 |
Two Sigma Investments
New York
|
-$5.97M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.3M |
| 5 |
Renaissance Technologies
New York
|
-$4.36M |
CDLX Hedge Fund Activity: Q1 2022 in Review
153 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q1 2022, worth a combined $1.83B — down 16% from $2.17B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of CDLX and 22 opened new positions — a net loss of 9 holders — while 49 trimmed existing stakes and 57 added.
The largest buyer was JS Capital Management, adding an estimated $23.4M. The largest seller was Wellington Management Group, cutting an estimated $11.1M.
- 153 institutional investors held Cardlytics (CDLX) as of Q1 2022, down from 163 in Q4 2021.
- Funds reported $1.83B of Cardlytics stock for Q1 2022, down 16% quarter-over-quarter.
- 22 funds opened new Cardlytics positions in Q1 2022 and 31 closed out, a net change of -9 holders.
- The largest Cardlytics buyer in Q1 2022 was JS Capital Management, an estimated $23.4M added.
- The largest Cardlytics seller in Q1 2022 was Wellington Management Group, an estimated $11.1M sold.
Based on aggregated 13F filings for Q1 2022.